Relationship between cancer cell proliferation, tumour angiogenesis and Tl uptake in non-small cell lung cancer

Nuclear Medicine Communications

Volumn 27, Issue 12, 2006, Pages 989-997

  Fujita, Seigo ^a   Nagamachi, Shigeki ^a   Nishii, Ryuichi ^a   Wakamatsu, Hideyuki ^a   Futami, Shigemi ^a   Tamura, Shozo ^a   Matsuzaki, Yasunori ^a   Onizuka, Toshio ^b   Hatakeyama, Kinta ^b   Asada, Yujiro ^b  

^a Department of Second Surgery ^*  (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Angiogenesis; Cell proliferation; MIB 1 index; MVD; Non small cell lung cancer

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; CHLORIDE; KI 67 ANTIGEN; THALLIUM 201;

ADENOCARCINOMA; ADULT; AGED; ANALYTICAL PARAMETERS; ANGIOGENESIS; ARTICLE; CALCULATION; CANCER CELL; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NON INVASIVE PROCEDURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33750701818     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000243371.26507.3c     Document Type: Article

References (59)

1. Park BJ, Louie O, Altorki N. Staging and the surgical management of lung cancer. Radiol Clin North Am 2000; 38:545-561.
2. Dosaka-Akira H, Hommura F, Mishina T, Oqura S, Shimizu M, Katoh H, Kawakami Y. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis. Cancer Res 2001; 61:2500-2504.
3. Fong KM, Sekido Y, Minna JD. Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg 1999; 118:1136-1152.
4. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994; 79:573-582.
5. Sherr CJ. Cancer cell cycles. Science 1996; 274:1672-1677.
6. Gerdos J, Lemke H, Baisch H, Wacher HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation - associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133:1710-1715.
7. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of cell proliferation - associated human nuclear antigen defined by the monoclonal antibody Ki-67. Am J Pathol 1991; 138:867-873.
8. Schwarting R, Gerdes J, Niehus J, Jaeschke L, Stein H. Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods 1986; 90:65-70.
9. Poleri C, Morero JL, Nieva B, Vazquez MF, Rodriguez C, de Titto E, Rosenberg M. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma. Chest 2003; 123:1858-1867.
10. Grossi F, Loprevite M, Chiaramondia M, Ceppa P, Pera C, Ratto GB, et al. Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers. Eur J Cancer 2003; 39:1242-1250.
11. Tanaka F, Oyanagi H, Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, et al. Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer. Cancer Res 2003; 63:6791-6794.
12. Tanaka F, Ishikawa S, Yanagihara K, Miyahara R, Kawano Y, Li M, et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 2002; 62:7124-7129.
13. Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res 2001; 7:3410-3415.
14. Offersen BV, Pfeiffer P, Hamilton-Dutoit S, Overgaard J. Patterns of angiogenesis in non-small cell lung carcinoma. Am Cancer Soc 2001; 91:1500-1509.
15. Fontanini G, Lucchi M, Vignati S, Mussi A, Ciardiello F, De Laurentiis M, et al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst 1997; 89:881-886.
16. Yano T, Tanikawa S, Fujie T, Masutani M, Horie T. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer. Eur J Cancer 2000; 26:601-609.
17. Higashi K, Ueda Y, Sakuma T, Seki H, Oguchi M, Taniguchi M, et al. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. J Nucl Med 2001; 10:1489-1496.
18. Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998; 4:1334-1336.
19. Been LB, Suurmeijer AJ, Cobben DC, Jager PL, Hoekstra HJ, Elsinga PH. [18F]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging 2004; 31:1659-1672.
20. Cox PH, Belfer AJ, Pompe WB. Thallium-201 chloride uptake in tumors, a possible complication in heart scintigraphy. Br J Radiol 1976; 16:425-430.
21. Salvatore M, Carratu L, Porta E. Thallium-201 as a positive indicator for lung neoplasm: preliminary experiments. Radiology 1976; 121:487-488.
22. Tonami N, Hisada K. Clinical experience of tumor imaging with Tl-201 chloride. Clin Nucl Med 1977; 2:75-81.
23. Tonami N, Shuke N, Seki H, Takayama T, Taki S, Yokoyama K, et al. Tl-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989; 30:997-1004.
24. 201Tl SPET imaging in patients with lung tumor: Comparison with computed tomography. Nucl Med Commun 1996; 17:493-499.
25. 201Tl-SPECT for patients with solitary pulmony nodule - comparison study with biopsy method and tumor marker measurement. Kaku Igaku 2001; 38:737-745.
26. Takekawa H, Itoh K, Abe S, Ogura S, Isobe H, Sukou N, et al. Retention index of thallium-201 single photon emission computerised tomography (SPECT) as an indicator of metastasis in adenocarcinoma of the lung. Br J Cancer 1994; 70:315-318.
27. + uptake in cultured human glioma cells. Cell Mol Neurobiol 1995; 15:351-360.
28. 201Tl-thallous chloride in tumour cells: role of P-glycoprotein. J Nucl Med 1995; 39:122-128.
29. Brismar T, Collins VP, Kesselberg M. Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells. Brain Res 1989; 500:30-36.
30. 201Tl SPECT in the predication of mediastinal lymph nodes metastasis in patients with non small cell lung cancer (NSCLC). Kaku Igaku 2004; 1:1-7.
31. Hsu SM, Raine L, Fanger H. Use of Avidin-biotin complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-580.
32. The World Health Organization histological typing of lung tumours. Second edition. Am J Clin Pathol 1982; 77:123-136.
33. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717.
34. Yamamoto Y, Nishiyama Y, Satoh K, Ohkawa M, Kameyama K, Hayashi E, Tanabe M. Comparative evaluation of Tc-99m MIBI and Tl-201 chloride SPECT in non-small-cell lung cancer mediastinal lymph node metastases. Clin Nucl Med 2000; 25:29-32.
35. Cermik TF, Yuksel M, Karlikaya C, Doganay L, Ture M, Berkarda S. Thallium-201 SPECT in advanced non-small cell lung cancer: in relation with chemotherapeutic response, survival, distant metastasis and p53 status. Ann Nucl Med 2003; 17:369-374.
36. Kier AB. Plasma membrane properties of cultured local LM cell tumors and metastases from athymic (nude) mice. Cancer Lett 1990; 50:19-30.
37. +)-ATPase activity with growth of normal and transformed cells. Exp Cell Res 1974; 87:233-240.
38. Ishibashi M, Fujii T, Yamana H, Fujimoto K, Rikimaru T, Hayashi A, et al. Relationship between cancer cell proliferation and thallium-201 uptake in lung cancer. Ann Nucl Med 2000; 14:255-261.
39. Tominaga M, Sueoka N, Irie K, Iwanaga K, Tokunaga O, Hayashi S, et al. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67. Lung Cancer 2003; 40:45-53.
40. Mascaux C, Martin B, Verdebout JM, Meert AP, Ninane V, Sculier JP. Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53. Eur Respir J 2003; 21:753-758.
41. Haga Y, Hiroshima K, Iyoda A, Shibuya K, Shimamura F, Iizasa T, et al. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer. Ann Thorac Surg 2003; 75:1727-1733.
42. Takahashi S, Kamata Y, Tamo W, Koyanagi M, Hatanaka R, Yamada Y, et al. Relationship between postoperative and expression of cyclin E, p27, and Ki-67 in non-small cell lung cancer without lymph node metastases. Int J Clin Oncol 2002; 7:349-355.
43. Carbognani P, Tincani G, Crafa P, Sansebastiano G, Pazzini L, Zoni R, et al. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery. J Cardiovasc Surg 2002; 43:545-548.
44. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168:357-363.
45. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002; 40:2-11.
46. Lopez F, Belloc F, Lacombe F, Dumain P, Reiffers J, Bernard P, Boisseau MR. Modalities of synthesis of Ki-67 antigen during the stimulation of lymphocytes. Cytometry 1991; 12:42-49.
47. Bruno S, Darzynkiewicz Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in SHL-60 cells. Cell Proliferation 1992; 25:31-40.
48. Ishibashi M, Taguchi A, Sugita Y, Morita S, Kawamura S, Umezaki N, et al. Thallium-201 in brain tumor: the relationship between the tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 1995; 36:2201-2206.
49. Yan W, Song L, Liang Q, Fang Y. Progression analysis of lung squamous cell carcinomas by comparative genomic hybridization. Tumour Biol 2005; 26:158-164.
50. Yano S, Matsumori Y, Ikuta K, Ogino H, Doljinsuren T, Sone S. Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer. Int J Clin Oncol 2006; 11:73-81.
51. Heizman ER. The role of computed tomography in the diagnosis and management of lung cancer. Chest 1986; 89:237-241.
52. Herbst RS, Onn A, Sandler A. Angiogenesis and lung cancer: prognostic and therapeutic implications. J Clin Oncol 2005; 23:3243-3256.
53. Wu VW, Kwong DL, Sham JS. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol 2004; 71:201-206.
54. Holloway CL, Robinson D, Murray B, Amanie J, Butts C, Smylie M, et al. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 2005; 75:246-247.
55. Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005; 181:483-499.
56. Suga K, Kawakami Y, Zaki M, Yamashita T, Shimizu K, Matsunaga N. Clinical utility of co-registered respiratory-gated (99m)Tc-Technegas/MAA SPECT-CT images in the assessment of regional lung functional impairment in patients with lung cancer. Eur J Nucl Med Mol Imaging 2004; 31:1280-1290.
57. Shiraishi S, Tomiguchi S, Utsunomiya D, Kawanaka K, Awai K, Morishita S, et al. Quantitative analysis and effect of attenuation correction on lymph node staging of non-small cell lung cancer on SPECT and CT. AJR Am J Roentgenol 2006; 186:1450-1457.
58. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 48:2500-2507.
59. Sergiacomi G, Schillaci O, Leporace M, Laviani F, Carlani M, Manni C, et al. Integrated multislice CT and Tc-99m sestamibi SPECT-CT evaluation of solitary pulmonary nodules. Radiol Med 2006; 111:213-224.